Yale Jen
Stock Analyst at Laidlaw & Co.
(0.22)
# 4,536
Out of 5,237 analysts
16
Total ratings
12.5%
Success rate
-18.02%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Initiates: Buy | $25 | $14.10 | +77.30% | 1 | Apr 15, 2026 | |
| PTN Palatin Technologies | Initiates: Buy | $60 | $19.00 | +215.79% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.40 | +1,508.11% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $3.04 | +623.68% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences Holdings | Initiates: Buy | $5 | $1.02 | +390.20% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $52.94 | +98.34% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $11.06 | +71.79% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $120 | $6.40 | +1,775.00% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $122.13 | -60.70% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $0.68 | +70,166.27% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $225 | $1.63 | +13,746.15% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.96 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.39 | +2,464.10% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.63 | - | 1 | Aug 15, 2023 |
Kazia Therapeutics
Apr 15, 2026
Initiates: Buy
Price Target: $25
Current: $14.10
Upside: +77.30%
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $19.00
Upside: +215.79%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.40
Upside: +1,508.11%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $3.04
Upside: +623.68%
Senti Biosciences Holdings
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.02
Upside: +390.20%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $52.94
Upside: +98.34%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $11.06
Upside: +71.79%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $120
Current: $6.40
Upside: +1,775.00%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $122.13
Upside: -60.70%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $0.68
Upside: +70,166.27%
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.63
Upside: +13,746.15%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.96
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.39
Upside: +2,464.10%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.63
Upside: -